Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
NFL
U.S.
2024 Election
Local
World
Science
Technology
AI
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Wegovy, Zepbound
Zepbound vs. Wegovy: New clinical trial says this weight-loss medication sheds more pounds
Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), manufactured by Fortune 500 firm Eli Lilly & Co., bested competitor Wegovy (semaglutide),
Lilly's Zepbound tops Wegovy for weight loss in head-to-head trial
Eli Lilly said on Wednesday patients taking its obesity drug Zepbound lost 47% more weight than those who were given Novo Nordisk's Wegovy in the first large, head-to-head trial of the highly in-demand rival medicines.
Zepbound Outperforms Wegovy in Weight Loss Clinical Trial
Zepbound outperformed Wegovy for weight loss in a new clinical trial funded by Eli Lilly & Co., Zepbound's maker.
WebMD
5d
Wegovy vs. Zepbound: New Data Declares a Winner
People taking the weight loss drug Zepbound experienced dramatically greater weight loss than competitor Wegovy in the first head-to-head trial.
3d
Ozempic cuts drinking, Zepbound beats Wegovy, and a blood test detects 50 cancers: Pharma news roundup
Some patients taking weight-loss drugs, including popular GLP-1 treatments like Ozempic (NVO) and Wegovy, reported reducing ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Trending now
Murder suspect charged
Not guilty in subway death
China deploys 90 ships
On birthright citizenship
Cardiovascular disease risk
US renews push to find Tice
Women drop lawsuit
2024 word of the year
Targeted by a bomb threat
Red-flag warnings in CA
Declines to lift gag order
Deputy secretary of state
Kanlaon volcano erupts
Travel ban on SK president
Syria's chemical weapons hit
Ink distribution deal
Bans cancer causing solvents
China opens investigation
Quakes hit Alaska islands
Seeks to pause US ban
Baseball’s HOF inductees
Swift’s Eras Tour ends
Trust restructuring fails
X removes image generator
Osprey flights paused again
NJ fines sports betting firms
Golden Globes nominations
Set to take witness stand
Judge reviews Infowars sale
Feedback